Published in Br Med J (Clin Res Ed) on May 14, 1988
Trends in survival for childhood cancer in Britain diagnosed 1971-85. Br J Cancer (1990) 2.10
Palliative care for children with cancer--home, hospital, or hospice? Arch Dis Child (1990) 2.10
Are the children of fathers whose jobs involve contact with many people at an increased risk of leukaemia? Occup Environ Med (1999) 1.76
Clinical management of brain stem glioma. Arch Dis Child (1999) 1.32
Endocrine consequences of treatment of malignant disease. Arch Dis Child (1989) 1.26
Long term survival and cure after childhood cancer. Arch Dis Child (1989) 1.22
Endocrine deficit after fractionated total body irradiation. Arch Dis Child (1992) 1.12
Childhood cancer and paternal employment in agriculture: the role of pesticides. Br J Cancer (1998) 1.12
Childhood cancer: cure at what cost? Arch Dis Child (1990) 1.02
Paediatric home care in the UK. Arch Dis Child (1993) 0.99
Impaired pubertal growth in acute lymphoblastic leukaemia. Arch Dis Child (1991) 0.98
Cancer in young people in the north of England, 1968-85: analysis by census wards. J Epidemiol Community Health (1993) 0.98
Lessons from 20 years of curative therapy of childhood acute leukaemia. Br J Cancer (1992) 0.98
The late effects of cancer therapy in childhood. Br J Cancer (1991) 0.88
Childhood leukaemias in New Zealand: time trends and ethnic differences. Br J Cancer (1996) 0.88
Paediatric oncology and intensive care treatments: changing trends. Arch Dis Child (1999) 0.86
Endocrine disorders following treatment of childhood brain tumours. Br J Cancer (1990) 0.86
Sarcomas in north west England: III. Survival. Br J Cancer (1992) 0.84
Intracranial tumours in the first 18 months of life. Childs Nerv Syst (1990) 0.82
Screening for neuroblastoma. Arch Dis Child (1991) 0.80
Advances in paediatric cancer treatment. Transl Pediatr (2014) 0.76
Has modern management improved the outcome of infants with intracranial tumors? Childs Nerv Syst (1990) 0.76
The impact of age at diagnosis on socioeconomic inequalities in adult cancer survival in England. Cancer Epidemiol (2015) 0.75
Childhood cancer mortality in Austria, 1980-1992. Eur J Epidemiol (1997) 0.75
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
A classification scheme for childhood cancer. Int J Cancer (1987) 4.24
Incidence of second primary tumours among childhood cancer survivors. Br J Cancer (1987) 3.26
Centralisation of treatment and survival rates for cancer. Arch Dis Child (1988) 3.23
Survival in childhood acute lymphocytic leukemia: effect of protocol and place of treatment. Cancer Invest (1983) 2.16
Nephroblastoma: treatment during 1970-3 and the effect on survival of inclusion in the first MRC trial. Br Med J (1979) 1.84
Influence of place of treatment on diagnosis, treatment, and survival in three pediatric solid tumors. J Clin Oncol (1984) 1.72
Decline in US childhood cancer mortality. 1950 through 1980. JAMA (1984) 1.30
Advances in managing childhood cancer. Br Med J (Clin Res Ed) (1987) 1.23
Trends in cancer survival among U.S. white children, 1955-1971. J Pediatr (1975) 0.98
Childhood cancer survival trends in Queensland 1956-80. Br J Cancer (1984) 0.90
The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26
Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science (1997) 8.90
A classification scheme for childhood cancer. Int J Cancer (1987) 4.24
Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst (1984) 4.01
A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet (1992) 3.63
A clinical study of type 2 neurofibromatosis. Q J Med (1992) 3.23
Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res (1994) 3.20
Methods of classifying and ascertaining children's tumours. Br J Cancer (1976) 3.11
Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification--an Intergroup Rhabdomyosarcoma Study. Cancer (1995) 3.11
Metronidazole in prevention and treatment of bacteroides infections after appendicectomy. Br Med J (1976) 3.05
Childhood leukaemia in North West England 1954-1977: epidemiology, incidence and survival. Br J Cancer (1981) 2.97
14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. Lancet (1987) 2.68
Incidence of malignant disease in childhood: a 24-year review of the Manchester Children's Tumour Registry data. Br J Cancer (1980) 2.40
Pituitary function after treatment of intracranial tumours in children. Lancet (1975) 2.25
A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. Hum Pathol (1995) 2.20
Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients. Int J Cancer (1987) 2.18
Predicting the onset of smoking in boys and girls. Soc Sci Med (1989) 2.10
Tenascin: cDNA cloning and induction by TGF-beta. EMBO J (1988) 2.01
Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc Natl Acad Sci U S A (1980) 2.00
Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther (1992) 1.99
Bone-metastasizing renal tumour of childhood. Br J Cancer (1978) 1.98
Sarcomas in north west England: I. Histopathological peer review. Br J Cancer (1991) 1.95
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia (2006) 1.88
Endocrine function following the treatment of acute leukemia in childhood. J Pediatr (1977) 1.86
Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst (1996) 1.85
Nephroblastoma: treatment during 1970-3 and the effect on survival of inclusion in the first MRC trial. Br Med J (1979) 1.84
Use of tumour marker immunoreactivity to identify primary site of metastatic cancer. BMJ (1993) 1.79
Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. Cancer Res (1991) 1.77
The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer (1994) 1.75
Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study. J Clin Oncol (1995) 1.74
Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol (1998) 1.71
Cytological grading of breast carcinoma--a feasible proposition? Cytopathology (1990) 1.70
Excess risk of breast cancer in the mothers of children with soft tissue sarcomas. Br J Cancer (1984) 1.70
A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling. J Med Genet (1992) 1.62
Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther (1995) 1.61
Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. BMJ (1992) 1.61
Activating communities for health promotion: a process evaluation method. Am J Public Health (1993) 1.60
The nucleotide sequence of Saccharomyces cerevisiae chromosome XIII. Nature (1997) 1.59
Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Oncogene (1998) 1.59
p53 germline mutations in Li-Fraumeni syndrome. Lancet (1991) 1.58
Testicular histology after combination chemotherapy in childhood for acute lymphoblastic leukaemia. Lancet (1978) 1.57
Are snake populations in widespread decline? Biol Lett (2010) 1.56
The nucleotide sequence of Saccharomyces cerevisiae chromosome IX. Nature (1997) 1.56
Omeprazole and Helicobacter pylori: temporary suppression rather than true eradication. Aliment Pharmacol Ther (1991) 1.56
Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team. N Engl J Med (1997) 1.56
Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients. JAMA (1988) 1.55
Metronidazole in prevention and treatment of bacteroides infections in elective colonic surgery. Br Med J (1977) 1.55
Isolation of Bacteroides corrodens from infections in children. J Clin Pathol (1971) 1.54
Campylobacter enteritis associated with the consumption of free school milk. J Hyg (Lond) (1981) 1.51
Light inactivation of metronidazole sensitivity discs. J Clin Pathol (1977) 1.51
Normal growth despite abnormalities of growth hormone secretion in children treated for acute leukemia. J Pediatr (1979) 1.50
Cervical carcinoma: prognosis in younger patients. Br Med J (Clin Res Ed) (1987) 1.50
Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008. Diabet Med (2014) 1.49
Neuroblastoma--when are urinary catecholamines and their metabolites 'normal'? Ann Clin Biochem (1988) 1.48
Cancer in the families of children with soft tissue sarcoma. Cancer (1990) 1.47
Patterns of multiple primary tumours in patients treated for cancer during childhood. Br J Cancer (1987) 1.45
Identification of factors associated with high breast cancer risk in the mothers of children with soft tissue sarcoma. J Clin Oncol (1990) 1.45
Multileaf collimator interleaf transmission. Med Phys (1999) 1.44
cDNA and gene nucleotide sequence of porcine plasminogen activator. Nucleic Acids Res (1984) 1.43
Acid degradation of erythromycin A and erythromycin B. Experientia (1971) 1.43
Residual disabilities in children treated for intracranial space-occupying lesions. Cancer (1976) 1.41
Acute lymphoid leukaemia of childhood in North-West England. Lancet (1979) 1.41
Neurohormones from fish tails: the caudal neurosecretory system. I. "Urophysiology" and the caudal neurosecretory system of fishes. Recent Prog Horm Res (1985) 1.39
Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain. Br J Cancer (2004) 1.39
Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J Hum Genet (1995) 1.37
Growth hormone deficiency after treatment of acute leukaemia in children. Arch Dis Child (1976) 1.36
Mutations affecting excision of the intron from a eukaryotic dimeric tRNA precursor. EMBO J (1984) 1.35
Nonsense suppression in Schizosaccharomyces pombe: the S. pombe Sup3-e tRNASerUGA gene is active in S. cerevisiae. Mol Gen Genet (1982) 1.34
Pre-treatment serum levels of tumour markers in metastatic breast cancer: a prospective assessment of their role in predicting response to therapy and survival. Eur J Surg Oncol (1995) 1.34
Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut (2004) 1.33
Absence from school related to children's and parental smoking habits. BMJ (1989) 1.32
Nonenzymatic acetylation of histones with acetyl-CoA. Biochim Biophys Acta (1970) 1.32
Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol (1995) 1.31
The effect of varying doses of cerebral irradiation on growth hormone production in childhood. Clin Endocrinol (Oxf) (1976) 1.31
Gentamicin in childhood infections. Curr Ther Res Clin Exp (1970) 1.26
"Eradication" of Campylobacter pylori: are we being misled? Lancet (1988) 1.26
Gastroenteritis following ingestion of sewage-polluted water: an outbreak at a logging camp on the Olympic Peninsula. Am J Epidemiol (1969) 1.25
Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab (2002) 1.25
Mutations preventing expression of sup3 tRNASer nonsense suppressors of Schizosaccharomyces pombe. Mol Cell Biol (1985) 1.24
Constitutive expression of the urokinase plasminogen activator gene in murine RAW264 macrophages involves distal and 5' non-coding sequences that are conserved between mouse and pig. Nucleic Acids Res (1991) 1.24
Benchmarking beam alignment for a clinical helical tomotherapy device. Med Phys (2003) 1.24
Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease. Cochrane Database Syst Rev (2000) 1.24
Implementation of the Henry J. Kaiser Family Foundation's Community Health Promotion Grant Program: a process evaluation. Milbank Q (1998) 1.23
Diagnostic criteria for adult respiratory distress syndrome: time for reappraisal. Lancet (1989) 1.23
Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party. Eur J Cancer (1997) 1.22
Biosecurity-based interventions and strategies to reduce Campylobacter spp. on poultry farms. Appl Environ Microbiol (2011) 1.22
Inhibition of protein synthesis in LLC-PK1 cells increases calcitonin-induced plasminogen-activator gene transcription and mRNA stability. Biochem J (1987) 1.21
Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies. Cancer (1989) 1.21
Neurofibromatosis in children with soft tissue sarcoma. Pediatr Hematol Oncol (1988) 1.21
Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation. N Engl J Med (1988) 1.20
Radiotherapy in seminoma of the testis. Clin Radiol (1983) 1.20
Lung function and exercise capacity in survivors of childhood leukaemia. Med Pediatr Oncol (1995) 1.19